6640--CPT - Blood Bank Immunohematology Analyzer 5 YR BPA - Ann Arbor

Awarded Limited / Sole Source Justification Posted

Solicitation number
36C25023Q0761
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
36C25024A0001-36C25024A0001 Federal IDV award

Notice details come from SAM.gov. Updated .

About this opportunity

This Limited/Sole Source Justification Notice from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 10 seeks to award a blanket purchase agreement to Ortho Clinical Diagnostics for an automated blood bank immunohematology system, including an Ortho Vision analyzer, startup reagents, consumables, and maintenance over a base year and four option years. The agency justified restricting consideration to the incumbent, Ortho Clinical Diagnostics, due to the equipment's compatibility with the agency's existing Ortho manual backup system and interface with its Cerner EHR system, and the lack of any other capable vendors identified through market research. The contract was awarded to Ortho Clinical Diagnostics for an unknown amount on October 1, 2023.

Notice text

VHAPG Part 808.405-6 Limiting Sources

Attachment 2: Request for Limited Sources Justification Format >SAT

Effective Date: 02/01/2022 Page 1 of 4

LIMITED SOURCES JUSTIFICATION

ORDER >SAT

FAR PART 8.405-6

Acquisition Plan Action ID: 36C250-23-AP-3656

(1) Contracting Activity: Department of Veterans Affairs, Network Contracting Office 10, located at 24 Frank Lloyd Wright Drive, Ann Arbor, MI 48105, in support of Ann Arbor VA Healthcare System at 2215 Fuller Road, Ann Arbor, MI 48105. 506-24-1-1030-0002

(2) Description of Action: This acquisition is conducted under the authority of the Multiple-Award Schedule Program (41 U.S.C. 152(3) and 40 U.S.C. 501). This is a new requirement for an FSS-BPA with a base year plus four 1-year option periods for blood bank immunohematology system for automation in the Blood Bank Department and Laboratory Medicine Services at the Ann Arbor VA Healthcare System.

Order against: FSS Contract Number: V797D-60637 (ex. 7/14/2031 inclusive of options)

Name of Proposed Contractor:

Ortho Clinical Diagnostics

Street Address:

1001 US Highway 202

City, State, Zip:

Raritan, NJ 08869

Phone:

585-453-5556

(3) Description of Supplies or Services:

The procurement is to provide the Pathology Service with blood bank automation and use the same backup method and reagents, currently in use. The automated blood bank system includes reagents, gel cards, reagent red blood cells, antisera, software, hardware, UPS (uninterrupted power supply), all parts and materials, technical manuals, consumable supplies, shipping, and handling costs associated with receipt of reagents, startup reagents and consumables required to bring the analyzer on operational level, preventative maintenance and emergency repair maintenance agreement, operator training in the operation of and performance of preventive maintenance on the automated blood bank testing system.

Ortho Vision Analyzer 6904577 1 Each

Ortho Vision Startup Reagent Allowance 14572251H 1 Each

Ortho Vision Table 6904701 1 Each

Printer (OV) Lexmark 6986685 1 Each

Description

Product Code

FSS/Open Market

MTS A/B/D Group (5 x 20)

MTS081115

FSS

MTS A/B/D Mono & Reverse Grp Card (5 x 20)

MTS080515

FSS

MTS Anti-IgG Card (5 x 20)

MTS084024

FSS

0.8% Affirmagen (2 x 10 mL)

719201

OM

0.8% RESOLVE Panel A (11 x 3 mL)

6902317

OM

0.8% RESOLVE Panel B (11 x 3 mL)

6902318

OM

0.8% Selectogen (2 x 10 mL)

6902315

OM

ORTHO CONFIDENCE SYSTEM

6902096

OM

COOMBS CONTROL 1X10ML

719810

OM

SURGISCREEN 3X10ML

719100

OM

AFFIRMAGEN 2X10ML

719210

OM

MTS Diluent 2 (5 x 100 mL)

MTS9230

FSS

MTS Diluent 2 Plus (5 x 100 mL)

MTS9330

FSS

ORTHO 7% BSA (12 x 5mL)

6844285

FSS

OV Dilution Trays (16-well tray - 180/ box)

6904591

FSS

OV Evaporation Caps 10 mL (250/ box) for Reagent Red Cells

6843005

FSS

(4) Identify the Authority and Supporting Rationale (see below and if applicable, a demonstration of the proposed contractor s unique qualifications to provide the required supply or service.

FAR 8.405-6(a)(1)(A): An urgent and compelling need exists and following the ordering procedures would result in unacceptable delays:

FAR 8.405-6(a)(1)(B): Only one source is capable of providing the supplies or services required at the level of quality required because the supplies or services are unique or highly specialized;

During Market Research for the testing system, there were four main factors which were

considered. Different vendors were evaluated for these main factors.

1. The system must use gel column agglutination technology. Ortho Vision Swift does

use a gel column agglutination technology.

2. Compatibility with the existing and purchased manual backup system, which is from

Ortho. We do not have the means nor resources to validate new testing methodology,

completely change all Standard Operating Procedures and train all staff within the next fiscal year. Only Ortho Vision Swift is compatible with the existing manual backup system.

3. Midsize instrument that will justify the workload of VA Ann Arbor Healthcare System. System should not be too small and at the same time it should not be too big, requiring re-construction in the blood bank. Vendor must supply an analyzer capable of bench top installation. Ortho Vision Swift is a benchtop and a midsize instrument.

4. The instrument is interface approved for use with CERNER, without a middleware. VA Ann Arbor Healthcare System has been working with Oracle-Cerner EHRM for the last couple years anticipating Ortho Vision as the default automation. Ortho Vision Swift is capable of interfacing with CERNER without a middleware.

The other factors that were considered in source selection were:

1. The ID-Micro Typing System (Gel Column Testing), manufactured by Ortho Clinical

Diagnostics has been in use in this laboratory since 1998 using manual method and 2008

using automated methodology.

2. For many years, VA Ann Arbor Healthcare System has used this system as our Primary

method for ABO/Rh testing and antibody identification methodologies. The Ortho Vision is

compatible with the Laboratory s existing manual ID-MTS-Gel system/technology

(Secondary method) and VA owned equipment currently in use. Both systems use the same

reagent and consumables.

3. Ortho Clinical Diagnostics has been the leader in Gel Column Agglutination testing,

competitors have not been FDA approved or an industry standard longer than Ortho. Ortho

is the gold standard in gel technology. It is also used by the University of Michigan Trauma Center.

4. With a primary emphasis on employee safety, standardization, and sensitivity. VA Ann Arbor Healthcare System relies on this system for ease of use, quicker turnaround times

and best standardization of Veteran care. All staff is trained and fully competent with the

Gel methodology versus the learning curve and restructuring with other methodologies.

5. The VA Ann Arbor Healthcare System currently maintains a contract for goods and services with Ortho Clinical Diagnostics. This vendor has demonstrated the ability to supply

automated and non-automated reagents for blood bank testing under their own brand.

6. Local hospitals within proximity to the VA Ann Arbor Healthcare System use Ortho Vision.

This was convenient during the pandemic. When supply chain issues affected delivery

schedules, we had the ability to share reagents and supplies from the same vendor. This

bridged the time delay and continued quality care for our veterans.

7. In our current contract, we have seen best performance of the analyzer with very little

downtime. Whenever there is a downtime or an issue with the analyzer hindering its

operation, the contractor has been very diligent about fixing the issue in a decent and

reasonable time frame and helping in providing continuity of best patient care to our

veterans. We have seen best customer support from the contractor during the period of

FY18 till date.

8. VA Ann Arbor Healthcare System has been preparing for the Oracle Cerner EHRM Project.

This process has been ongoing for the past 2 years, adjusting workflows and preparing for

the transition. Ortho Vision is by far the most common throughout the domain and is

currently setup as a default build in CERNER Millennium, though there are several other

devices setup too. Switching off the Vision would require a medium amount of rework to

ensure the CERNER build is set to accept those results. The transition to CERNER millennium, would benefit from the continued use of Ortho gel methodology.

FAR 8.405-6(a)(1)(C): In the interest of economy and efficiency, the new work is a logical follow-on to an original Federal Supply Schedule order provided that the original order was placed in accordance with the applicable Federal Supply Schedule ordering procedures. The original order must not have been previously issued under sole source or limited source procedures.

FAR 8.405-6(b): Items peculiar to one manufacturer:

A patent, copyright or proprietary data limits competition. The proprietary data is:

These are direct replacements parts/components for existing equipment.

The material/service must be compatible in all aspects (form, fit and function) with existing systems presently installed/performing.

(5) Describe Why You Believe the Order Represents the Best Value consistent with FAR 8.404(d) to aid the contracting officer in making this best value determination:

The Ortho Vision is compatible with the laboratory s existing manual ID-MTS-Gel system/technology (Secondary method) and VA owned equipment currently in use. Both systems use the same reagent and consumables. With a primary emphasis on employee safety, standardization, and sensitivity, the VA Ann Arbor Healthcare System relies on this system for ease of use, quicker turnaround times and best standardization of veteran care. All staff is trained and fully competent with the gel methodology versus the learning curve and restructuring with other methodologies. Local hospitals within proximity to the VA Ann Arbor Healthcare System also use Ortho Vision. This is a benefit because if supply chain issues affect delivery schedules, we can share reagents and supplies from the same vendor. This bridges the time delay and continues quality care for our veterans. The work with CERNER has been ongoing for 2 years and Ortho Vision is currently being set up as a default build in CERNER Millennium. Switching off the Ortho Vision would require a medium amount of rework to ensure the Cerner build is set to accept those results. The transition to CERNER Millennium, would benefit from the continued use of Ortho gel methodology and would be a cost savings for the government.

(6) Describe the Market Research Conducted among schedule holders and the results or a statement of the reason market research was not conducted.

VetCert was searched under NAICS 334516 and 188 SDVOSB/VOSB concerns were found. Searched DSBS under NAICS 334516 and keyword Immunohematology and zero concerns were found. NAICS 334516 has a waiver for some items; however, this specific equipment is not listed. Also, Ortho-Clinical Diagnostics is a large business with no SDVOSB/VOSB distributors for this type of contract. The VA Rule of Two cannot be met. Most items are on their NAC contract; however, in accordance with FAR 8.402(f), it is allowable to add open market items to a FSS procurement if it meets the requirements under this section. An intent to sole source was posted to Contract Opportunities from May 25, 2023 through June 2, 2023 with no responses. Ortho-Clinical Diagnostics is the only vendor that can provide these exact items.

(7) Any Other Facts Supporting the Justification:

There are no other supporting facts.

(8) A Statement of the Actions, if any, the agency may take to remove or overcome any barriers that led to the restricted consideration before any subsequent acquisition for the supplies or services is made:

Should the Government have a future need for this requirement, the Government will continue to conduct market research to ascertain if there are changes in the marketplace that would enable future actions to be competed. Awarded contract 36C25024A0001 to ORTHO-CLINICAL DIAGNOSTICS INC for unknown amount on 2023-10-01.

Files

File Type Posted
36C25024A0001_1.docx DOCX document

Notice history

Notice Type Posted
This notice Latest Limited / Sole Source Justification
6640--Blood Bank Immunohematology Analyzer 5 YR BPA Latest special notice Special Notice

Similar open opportunities

Opportunity Agency Set-aside Responses due
6550--Blood Type IVD Reagents Visn 22 Sites · NAICS 325413 Veterans Integrated Service Network 22 No set-aside
6550--Blood Bank Reagents Department of Veteran Affairs Dallas VA North Texas HealthCare System Dallas, Texas 75216, United States · NAICS 325413 Veterans Integrated Service Network 17 No set-aside
BPA - Consumable Supplies for Terumo Trima Accel Blood Collection systems Jbsa Ft Sam Houston, Texas 78234, United States · NAICS 325413 Defense Health Agency Service-Disabled Veteran-Owned Small Business
6550--VISN 4 Coagulation Testing Pittsburgh, Pennsylvania 15215, United States · NAICS 334516 Veterans Integrated Service Network 4 No set-aside
BPA - Blood Transfusion Services Wright Patterson AFB, Ohio 45433, United States · NAICS 621991 AFLCMC Wright Patterson AFB No set-aside

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors